Browsing by Author "Dragana, Vujic (16647611700)"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Treatment results of childhood acute myeloid leukemia in Serbia(2013) ;Nada, Krstovski (29467677800) ;Milos, Kuzmanovic (6602721300) ;Dragana, Vujic (16647611700) ;Lidija, Dokmanovic (29467699700) ;Dragan, Micic (55152371100) ;Bojana, Slavkovic (6507636002) ;Dejan, Skoric (34970820800) ;Jelena, Lazic (56963809700) ;Ankica, Jovanovic (55548294400) ;Milena, Jovic (55548219100) ;Nada, Konstantinidis (6603870463) ;Gordana, Kostic (55547781600) ;Predrag, Rodic (15846736800)Dragana, Janic (15729368500)We present the results of a retrospective study of acute myeloid leukemia (AML) treatment in Serbia in the period 2000-2012. Treatment was performed in four centers, two of which were located in Belgrade, one in Nis, and one in Novi Sad. Children affected by non-acute promyelocytic leukemia (non-APL) subtypes received treatment regimens derived from protocols of Berlin Frankfurt Munster AML study group, whereas children with APL were treated according to the AIEOP/GIMEMA ATRA plus Idarubicin "AIDA" protocol. Total number of patients was 106, out of whom 48 were girls (45.3 %) and 58 boys (54.7 %); median age at diagnosis was 9.0 years (range 1 month-17.9 years). In total, 82.1 % of patients achieved complete remission after induction treatment. Twelve patients (11.3 %) died during induction, before achieving complete remission; there were nine deaths during remission (10.5 %) and 20 patients relapsed (23.2 %). Median time of follow-up was 54 months. Two patients (1.9 %) were lost to follow-up. Event-free survival was 50.3 % and overall survival was 58.9 %. © 2012 Springer-Verlag Wien.
